Although combinatorial signaling through the ErbB network is implicated in certain types of human cancer, the specifics of how particular receptors contribute to the transformed phenotype are not well understood. The goal of this study was to identify epidermal growth factor (EGF) receptor-dependent cell signaling abnormalities specifically associated with mutations in a previously described 679-LL lysosomal sorting signal, which restrict ligand-dependent receptor downregulation by promoting recycling. Importantly, the 679-LL signal is not conserved in any of the other members of the ErbB receptor family suggesting its physiological function may be tightly regulated during EGF receptor-dependent signaling. Our data indicate that cells expressing receptors with an inactive 679-AA signal are rapidly transported to Rab4 þ early endosomes after they are internalized in contrast to wild-type receptors that are localized to early endocytic antigen 1 (EEA1) þ early endosomes. Divergent trafficking in early endosomes is associated with prolonged activation of p44/42 mitogen-activated protein kinases (MAPK) but not Akt. Gab1 appears to be the critical signaling molecule facilitating prolonged MAPK signaling, and activated Gab1 is recruited to early endosomes in 679-AA receptor-expressing cells. Activated Gab1 is also recruited to early endosomes in breast cancer cells characterized by high levels of EGF receptor-ErbB2 heterodimers, suggesting 679-AA expressing cells recapitulate certain aspects of EGF receptor signaling and transformation by activated ErbB2. Phosphatidylinositol 3-kinase (PI3K)-dependent membrane translocation known to be important for maintaining Gab1 activity in other settings was dispensable. We conclude that 679-LL has dual functions in EGF receptor trafficking and threshold signaling through a subset of signaling molecules including p44/42 MAPK and Gab1.
Introduction
The ErbB signaling network has significant roles in many cellular processes including proliferation, survival, migration and differentiation, and perturbed ErbB signaling is associated with cell transformation (Alroy and Yarden, 1997; Wiley and Burke, 2001; Yarden and Sliwkowski, 2001 ). This family is comprised of four related receptor tyosine kinases (epidermal growth factor receptor (EGFR) or ErbB1, ErbB2, ErbB3, and ErbB4) and more than 30 ligands in humans. Signaling output is both diverse and flexible because of different ligand-receptor complexes' capacity to form heterodimers. ErbB signaling is also strongly influenced by receptor-mediated endocytosis, which controls how receptors sort once they have been activated. EGFR signaling is tightly controlled because activated receptors are rapidly internalized and targeted to lysosomes for degradation. None of the other ErbB receptors are significantly downregulated, leading to differences in signal output and amplification (Waterman and Yarden, 2001) . Besides orchestrating protein sorting, endocytic organelles play an active role in signal propagation by compartmentalizing the assembly of specific signaling complexes necessary to elicit different cellular responses (Sorkin and Von Zastrow, 2002; Miaczynska et al., 2004) . Heterodimerization with its preferred receptor partner ErbB2 suppresses EGFR downregulation leading to abnormalities in EGFR signaling and cell transformation, and has been implicated as an important factor in sporadic human breast cancers (Karunagaran et al., 1996; Lenferink et al., 1998; Olayioye et al., 1998; Wang et al., 1999; Citri et al., 2003; Hendriks et al., 2003) . Thus understanding ErbB2-dependent regulation of EGFR function is vital for designing novel therapies aimed at treating many human cancers with ErbB2 expression abnormalities (Yarden and Sliwkowski, 2001) .
One approach to understanding the molecular basis of alternative ErbB receptor sorting is to correlate lack of function with divergent sequences found in different ErbB receptors. Analysis of ErbB receptor chimeras has revealed that EGFR cytoplasmic tails are necessary for ligand-induced internalization, degradation in lysosomes, and in vitro association with the plasma membrane clathrin adaptor AP-2 (Baulida et al., 1996) . Some specific EGFR sequences implicated in postendocytic sorting to lysosomes include the carboxyl terminal sequence 954-YLVI, originally identified as a SNX-1 binding site (Kurten et al., 1996; Jones et al., 2002) , and a juxtamembrane domain leucine-based signal 679-LL identified by this laboratory (Kil et al., 1999; Kil and Carlin, 2000) (see Figure 1a ). Tyr1045 is also important for ligand-induced downregulation, as it binds and activates c-Cbl, a ubiquitin ligase involved in multiple sorting steps (Marmor and Yarden, 2004) . While 954-YLVI signal is relatively conserved across the entire ErbB family, and the c-Cbl docking site is common to EGFR and ErbB2, 679-LL is only found in EGFR (Figure 1a ). Thus 679-LL function is a potential target for deregulation in EGFR-ErbB2 heterodimers.
The 679-LL signal was originally identified in a screen for latent lysosomal sorting signals exposed by introducing premature stop codons in the EGFR cytoplasmic tail (Kil et al., 1999) . The physiological function of this signal was tested in stable mouse cell lines lacking endogenous receptors, which had been transfected with EGFRs containing a mutated 679-AA signal. The mutated 679-AA receptors were activated and underwent rapid internalization following ligand stimulation similar to wild-type receptors (Kil et al., 1999; Kil and Carlin, 2000) . They were, however, excluded from late endosomes and recycled back to the plasma membrane. As EGFR recycling is known to be relatively slow compared to internalization (approximately 15 min versus 4-5 min, respectively) (Wiley, 2003) , the net effect of the 679-AA mutation is to increase the pool of receptors in early endosomes compared to wild-type receptors. We have also demonstrated that 679-LL is an a-helical stabilizing motif, distinguishing it from other dileucine-based sorting signals with obligatory aminoterminal acidic residues that are recognized in the form of an extended b or b-like conformation and suggesting that it has a novel mode of action (Bonifacino and Traub, 2003; Tsacoumangos et al., 2005) . Furthermore, EGFRs with a mutated 679-AA sequence interact with c-Cbl and undergo protein ubiquitination suggesting this protein modification is not sufficient for EGFR downregulation Tsacoumangos et al., 2005) .
The goal of this study was to identify EGFRdependent cell signaling abnormalities specifically associated with the 679-AA mutation. These studies are important for several reasons. First, receptors with a 679-AA sequence could exhibit amplified signaling from early endosomes. Second, the 679-LL signal may play a unique role in EGFR signaling as is not conserved in the corresponding regions of any of the other ErbB receptors (Figure 1a) . Third, examination of signaling by receptors with a 679-AA sequence may also give insights to pathways affected when normal EGFR trafficking to lysosomes is suppressed by heterodimer formation. Our results indicate that the 679-AA receptor is specifically associated with amplified signaling through a subset of EGFR-dependent signaling molecules that include p44/42 mitogen-activated protein kinases (MAPK) and Gab1 but not Akt. Gab1 is a multisubstrate adaptor protein capable of stimulating several signaling pathways after it is recruited to activated receptors and undergoes tyrosine phosphorylation (Gu and Neel, 2003) . Gab1 regulates MAPK signaling via an unknown substrate of Shp2 (Cai et al., 2002) , a tyrosine phosphatase that is activated after it is recruited to a bisphosphoryl tyrosine-based Gab1 binding site that includes phospho-Tyr627 (Cunnick et al., 2001) . Although many studies have pointed to a role for the endocytic machinery, our data specifically implicate Rab4 þ early endosomes as critical platforms for controlling cell signaling through this particular subset of EGFR-dependent pathways.
Results 679-AA receptor trafficking defect associated with enhanced biological activity and increased sorting to EEA1
þ early endosomes NR6 cells were used in these studies as they lack endogenous EGFRs (Pruss and Herschman, 1977) , and also because ErbB2 is expressed at very low levels ( Figure 1b) . Thus, any changes in cell signaling can be attributed to specific mutations in transfected EGFR gene products without confounding effects from endogenous homo-or heterodimer partners. Cell lines also had equivalent amounts of wild-type or 679-AA receptors to eliminate effects owing to variations in receptor number (see Materials and methods). Figure 1c shows that pulse-labeled wild-type receptor protein delivered to plasma membrane is substantially reduced 45 min after EGF is added to the cells, in contrast to the 679-AA receptor where unstimulated and stimulated cells have similar levels of receptor protein. These results confirm previous findings that 679-AA receptors do not undergo EGF-induced downregulation to the same extent as wild-type receptors (Kil et al., 1999; Kil and Carlin, 2000) . The variable capacity for downregulation is paralleled by differences in receptor activation. Whereas initial levels of ligand-induced receptor autophosphorylation were markedly reduced by 45 min poststimulation in cells with wild-type EGFR, 679-AA receptor autophosphorylation levels remained elevated during the same interval (Figure 1d ). To determine whether the 679-AA mutation also affects biological activity, 3 H-thymidine incorporation assays were carried out to measure DNA synthesis in G1-arrested cells stimulated with various EGF concentrations of for 19 h. The 679-AA receptor expressing cells exhibited an 8-to 10-fold increase in maximal DNA synthesis relative to cells with wild-type receptors (Figure 1g ). However, both cell lines displayed a comparable ED 50 for EGF (1-2 ng/ml; Figure 1e and f) indicating that different levels of DNA synthesis were achieved by the same receptor occupancy.
We had already established that wild-type and 679-AA receptors have similar rates of EGF-induced internalization . Furthermore EGFR recycling is known to be relatively slow compared to internalization (approximately 15 min versus 4-5 min, respectively) (Wiley, 2003) . Thus it seems likely that the net effect of the 679-AA mutation is to increase the pool of receptors in early recycling endosomes compared to wild-type receptors. This hypothesis was tested by staining cells pulsed with Alexa488-EGF for various early endosomal markers. Figure 2 shows that Alexa488-EGF-positive vesicles were also stained with an EGFR antibody, verifying that ligand and receptors are compartmentalized in the same endocytic vesicles in both cell lines. Alexa488-EGF partially overlapped with Rab5, which regulates clathrin-coated vesicle-mediated transport from the plasma membrane to early endosomes as well as homotypic early endosome fusion (Simonsen et al., 1998) , in both cell lines. Alexa488-EGF also extensively colocalized with early endocytic antigen 1 (EEA1), a Rab5 effector that mediates tethering and docking during homotypic fusion (Christoforidis et al., 1999) , in cells expressing wild-type EGFRs. This was in contrast to 679-AA receptor-expressing cells, where Alexa488-EGF-positive vesicles were largely devoid of this marker. Alexa488-EGF was largely excluded from vesicles positive for Rab4, which is involved in sorting and recycling in early (Marmor and Yarden, 2004) . Corresponding amino-acid sequences in other mammalian ErbB receptors are shown beneath the schematic. Dashed boxes highlight critical residues identified by site-directed mutagenesis (Kil et al., 1999; Kil and Carlin, 2000; Jones et al., 2002; Waterman et al., 2002) . (b) NR6 cells expressing wild-type human EGFR were pulse-labeled with 35 S-labeled amino acids for 30 min followed by a 3 h chase in media with an excess of nonradioactive amino acids. Cell lysates were immunoprecipitated with antibodies to human EGFR or ErbB2, and immunoprecipitates were resolved by SDS-PAGE for fluorographic detection. ErbB2 was immunoprecipitated from three dishes of the NR6-derived cells compared to one dish for EGFR, and the ErbB2 lane was exposed to film for 7 days, versus 24 h for EGFR. (c) Cells that were pulse-labeled with 35 S-labeled amino acids for 30 min followed by a 3 h chase were harvested immediately or 45 min post-EGF stimulation (100 ng/ml). EGFR immunoprecipitates were resolved by SDS-PAGE for fluorographic detection. (d) EGFR immunoprecipitates from untreated cells (À) or cells that were stimulated with EGF (100 ng/ml) for various times were resolved by SDS-PAGE, transferred to nitrocellulose, and immunoblotted for phosphotyrosine. (e-g) G1-arrested cells with wild-type (e) or 679-AA (f) receptors were stimulated with increasing concentrations of EGF for 19 h, and then labeled with endosomes (Daro et al., 1996) , in wild-type EGFRexpressing cells, compared to cells with 679-AA receptors where Alexa488-EGF exhibited extensive overlap with this marker. These data show for the first time that divergent 679-AA receptor trafficking most likely occurs at the level of early sorting endosomes, and support the hypothesis that the 679-AA mutation increases the pool of receptors in Rab4 þ early endosomes relative to what is typically seen with wild-type EGFR.
Activation of p44/42 MAPK and Akt signaling pathways As a first step towards identifying responses associated with enhanced sorting to EEA1
þ early endosomes, we compared the ability of wild-type and 679-AA receptors to activate two distinct signaling cascades: the p44/42 MAPK pathway, which has a central role in EGF-induced cell proliferation (Pearson et al., 2001) , and the Akt pathway necessary for cell survival (Downward, 2004) . Cellular signaling was synchronized by incubating cells with ligand at 41C to allow equilibrium binding at the cell surface, followed by warm-up to 371C to facilitate receptor trafficking. We also used relatively low concentrations of EGF (5 ng/ml) to avoid saturating endocytic sorting pathways. Total cellular protein from unstimulated cells and from cells treated with EGF for various times was analysed by immunoblotting with an antibody recognizing the activated forms of each class of signaling molecules. The top panel of Figure 3a shows that wild-type EGFRs elicit a transient p44/42 MAPK response with peak activity by 15 min poststimulation. In contrast, p44/42 MAPK activity was sustained for up to 60 min in cells expressing 679-AA receptors. As the observed differences were not due to sample variations (bottom panel of Figure 3a ), we conclude that 679-AA receptors elicit 
Rab5 EGF EGFR EGF
Figure 2 679-AA receptors exhibit divergent transport through early endocytic compartments compared to wild-type EGFR. Live cells were pulsed with Alexa488-EGF (100 ng/ml; green channel) for 10 min and then fixed and stained with antibodies to EGFR, Rab5, EEA1, or Rab4 (red channels). Stained cells were viewed by confocal microscopy. Green and red channels were merged after both fluorescent signals were adjusted to similar levels, and 'yellow' indicates the overlap of red and green fluorescence. The areas corresponding to enlarged insets shown on the right are boxed in all of the panels. Arrowheads denote colocalization of Alexa488-EGF and endocytic markers. Arrows denote Alexa488-EGF positive vesicles that do not overlap endocytic markers. Size bar, 10 mm.
EGF receptor signaling in early endosomes O Kostenko et al sustained p44/42 MAPK signaling relative to cells with wild-type receptors. This was in contrast to Akt, which was transiently activated peaking by 10 min poststimulation in both cell lines (Figure 3b) . Thus, the 679-AA mutation does not have a global impact on EGFRdependent signaling but affects specific signaling pathways.
Gab1 activity is enhanced in 679-AA receptor expressing cells To gain insight to the molecular basis for sustained p44/ 42 MAPK activation seen in cells with 679-AA receptors, we compared recruitment and/or activation of several signaling adaptor proteins known to be involved in this pathway in cell lines expressing each of the receptors. Figure 4a shows that cells with wildtype and 679-AA receptors express similar levels of Grb2 and Shc, two adaptor proteins that link activated receptors to SOS, which catalyses Ras GDP exchange initiating the MAPK signaling cascade (Margolis and Skolnik, 1994) . EGFR co-immunoprecipitation assays were used to test roles for Grb2 and Shc, as activated receptors form complexes with these adaptor proteins ( Figure 4 ). Each of these molecules showed similar levels of recruitment to wild-type and to 679-AA receptors (Figure 4c and d). Maximal recruitment occurred within 5-10 min after the 371C temperature-shift in both cell lines. Grb2 was associated with activated receptors transiently, in contrast to Shc where receptor association persisted for approximately 30 min in both cell lines (data not shown). Similar results were obtained for Crk, an adaptor protein which has also been linked to MAPK signaling (data not shown). Gab1 is another adaptor protein that has been linked to EGFR-dependent MAPK signaling. Gab1 is a signaling scaffold with multiple tyrosine phosphorylation sites for docking other target proteins. One of these targets is the tyrosine phosphatase Shp2, which promotes prolonged MAPK signaling by acting on an unknown intermediate necessary to maintain SOS in an active state (Cai et al., 2002) . To compare Gab1-dependent signaling in cells expressing wild-type versus 679-AA receptors, we first demonstrated that both cell lines have equivalent amounts of Gab1 as well as Shp2 (Figure 5a ). When Gab1 was examined in ligandstimulated cells, we observed that 679-AA receptorexpressing cells had a robust sustained response as evidenced by levels of tyrosine phosphorylated Gab1 detected by immunoblotting compared to their wild-type EGFR expressing counterparts (top panel, Figure 5b ). As the observed differences were not due to sample variations (bottom panel, Figure 5b ), we conclude that 679-AA receptors elicit enhanced Gab1 signaling relative to cells with wild-type receptors. Two approaches were used to determine whether Gab1 was coupled to Shp2 in 679-AA expressing cells. First, we showed that Gab1 was detected with an activationdependent Gab1 antibody recognizing the Shp2 docking site phospho-Tyr627 (middle panel, Figure 5c ). Second, we observed that Shp2 forms a stable complex with Gab1 in ligand-stimulated cells using a co-immunoprecipitation assay (right panel, Figure 5c ). Although we cannot exclude the possibility that the 679-AA substitution has a direct impact on Gab1 binding and/or activation, the simplest explanation for these data is that enhanced Gab1 activity is a result of these mutations' effect on receptor trafficking.
Gab1 activity in 679-AA receptor expressing cells persists in early endosomes Activated Gab1 translocates to cell membranes by a variety of different mechanisms that are discussed in later sections. Given the trafficking itinerary of 679-AA receptors, we hypothesized that these mutant receptors signal through Gab1-dependent pathways from early endocytic membrane compartments. We therefore determined the intracellular distribution of activated Gab1 by cell fractionation on iso-osmotic Percoll gradients. Fractions were first immunoblotted for various membrane compartment markers, including the transferrin receptor (plasma membrane and early endosomes) (Klausner et al., 1983; Lamb et al., 1983; Weiel and Hamilton, 1984) , Rab5 (plasma membrane and early endosomes) (Chavrier et al., 1990) , Rab4 (recycling early endosomes) (Daro et al., 1996) , Rab7 (late endosomes) (Feng et al., 1995) , and Lamp-1 (late endosomes and lysosomes) (Lippincott-Schwartz and Fambrough, 1987) (Figure 6a ). Based on marker distribution, we concluded that plasma membranes were concentrated in fraction 1, early endosomes in fractions 2-4, late endosomes in fraction 5, and lysosomes in fractions 5-6. We also verified that wild-type and 679-AA receptors cosediment with plasma membrane markers (Figure 6b ), indicating that the 679-AA substitution does not alter the ratio of receptors at the cell surface versus internal compartments in unstimulated cells. The intracellular membrane distribution of activated receptors and Gab1 were then determined by analyzing individual Percoll gradient fractions obtained from cells that had been stimulated with EGF for 10 min. Similar to results for total protein in the top panel of Figure 6b , activated wild-type EGFRs were concentrated in fraction 1 enriched for plasma membrane (data not shown). However, due to its low level of total tyrosine phosphorylation (Figure 5b) , it was not possible to detect activated Gab1 in any of the fractions obtained from wild-type EGFR-expressing cells (data not shown). When cells with 679-AA receptors were analysed, mutant receptors and Gab1 (top and bottom panels, respectively, Figure 6c ) were both tyrosine phosphorylated in membrane fractions from stimulated cells enriched for early endosomes (fractions 2-3) in addition to plasma membrane (fraction 1). We also used confocal microscopy to show that the activation-dependent Gab1 antibody recognizing the Shp2 docking site colocalized with Alexa488-EGF loaded early endosomes in 679-AA receptor-expressing cells (Figure 6d ). Altogether these data suggest that Gab1 activity persists in early endosomes in ligand-stimulated cells with forced EGFR recycling owing to the 679-AA substitution.
EGF-dependent Gab1 endosomal activity in an ErbB2-overexpressing breast cancer cell line Heterodimerization with its preferred receptor partner ErbB2 suppresses EGFR downregulation leading to abnormalities in EGFR signaling and cell transformation, and has been implicated as an important factor in sporadic human breast cancers (Karunagaran et al., 1996; Lenferink et al., 1998; Olayioye et al., 1998; Wang et al., 1999; Citri et al., 2003; Hendriks et al., 2003) . As EGFR downregulation is also suppressed in 679-AA receptor expressing cells, we were interested in whether these genetically engineered cells elicit any of the same responses as cancer cells characterized by high levels of EGFR-ErbB2 heterodimerization. This hypothesis was tested using SKBR3 breast cancer cells that have been used previously to study EGFR-ErbB2 heterodimer formation (Wang et al., 1999) . Despite abundant ErbB2 expression ( Figure 7a ) and basal activation (Figure 7b ), Gab1 activation was strictly EGF dependent ( Figure 7c ), implying an essential role for EGFR signaling. Results in Figure 7d show that activated Gab1 colocalizes with EGFR in early endosomes similar to what we observed in the 679-AA receptor expressing cell line. Although Gab1 signaling was previously linked to EGFR-dependent ErbB2 transformation (Yamasaki et al., 2003) , these data show for the first time that Gab1 is prominently activated in early endosomes in these cancer cells. These data also validate use of 679-AA expressing cells as a model for understanding EGFR signaling and transformation by activated ErbB2.
Gab1 forms ligand-inducible molecular complexes with 679-AA receptors Gab1 membrane recruitment is coordinated by several different mechanisms including direct binding to autophosphorylated receptor tyrosine kinases such as EGFR (Rodrigues et al., 2000) . To determine whether Gab1 interacts with activated 679-AA receptors, Gab1 protein complexes were immunoprecipitated from unstimulated (d) Live 679-AA receptor-expressing cells were pulsed with Alexa488-EGF (100 ng/ml; green channel) for 10 min and then fixed and stained with an antibody to phospho-Gab1 (pTyr627) (red channel) for confocal imaging. Green and red channels were merged after both fluorescent signals were adjusted to similar levels, and 'yellow' indicates the overlap of red and green fluorescence. The areas corresponding to enlarged insets shown on the right are boxed in all of the panels. Arrows denote Alexa488-EGF positive vesicles that overlap phospho-Gab1. Size bar, 10 mm.
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or EGF-treated cells, and Gab1-associated proteins were analysed by immunoblotting with an EGFRspecific antibody. This analysis showed that activated Gab1 which could be detected with a phospho-Tyr627 Gab1 antibody (Figure 8b ), forms a stable complex with 679-AA receptors that persists for at least 15 min poststimulation (Figure 8c ; Figure 8a is a Gab1 loading control).
679-AA receptor-mediated Gab1 and MAPK signaling display differential sensitivity to PI3K inhibitors
Gab1 has a pleckstrin homology (PH) domain that facilitates phosphatidylinositol 3-kinase (PI3K)-dependent translocation to cell membranes in ligand-stimulated cells (Rodrigues et al., 2000) . PH domain-dependent recruitment may be the primary mode for Gab1 membrane translocation, or may reinforce membrane association secondary to direct receptor tyrosine kinase binding (Gu and Neel, 2003) . Having established that Gab1 binds directly to 679-AA receptors, we tested whether persistent Gab1 signaling was also PI3K-dependent by repeating ligand-induced activation assays in cells pretreated with two different PI3K inhibitors, LY294002 and wortmannin. Unexpectedly, these assays displayed differential sensitivities to these inhibitors. On the one hand, LY294002 had no effect on enhanced Gab1 activity (top panel of Figure 9a ; bottom panel is a Gab1 loading control), or on enhanced p44/42 MAPK S-labeled amino acids for 1 h followed by a 3 h chase with nonradioactive medium, and cell lysates were immunoprecipitated with antibodies to EGFR or ErbB2. (b) Lysates from untreated SK-BR-3 cells or cells that had been stimulated with EGF for 10 min were immunoprecipitated with antibodies to EGFR or ErbB2. Immunoprecipitates were immunoblotted with an antiphosphotyrosine antibody. (c) Cell lysates from unstimulated and EGF-stimulated cells were immunopreciptated with a Gab1-specific antibody and immunoprecipitates were immunoblotted for phosphotyrosine. (d) Cells were stimulated with EGF for 10 min, and then fixed and stained with antibodies to EGFR (green channel) or phospho-Gab1 (pTyr627) (red channel) for confocal imaging. Green and red channels were merged after both fluorescent signals were adjusted to similar levels, and 'yellow' indicates the overlap of red and green fluorescence. The area corresponding to enlarged insets shown on the right are boxed in all of the panels. Arrows denote EGFR-positive vesicles that overlap phospho-Gab1. Size bar, 10 mm. signaling (top panel of 9b; bottom panel is a MAPK loading control) characteristic of 679-AA receptorexpressing cells. In contrast, wortmannin prevented prolonged activation of both molecules, although Gab1 activation was initially robust similar to cells treated with dimethylsulphoxide (DMSO) vehicle. LY294002 and wortmannin completely blocked PI3K-dependent Akt signaling (Figure 9c ; bottom panel is an Akt loading control), suggesting that both of these compounds were effective PI3K inhibitors. We also showed that wortmannin does not increase 679-AA receptor degradation (data not shown). Thus, the wortmannin-induced effects on Gab1 and MAPK signaling are most likely due to another of this inhibitor's known effects on early endocytic trafficking (see Discussion). Based on results obtained with LY294002, we conclude that PI3K may not be important for enhanced signaling observed in 679-AA receptor-expressing cells.
Discussion
Membrane protein cargoes encounter several critical sorting stations during transport through the endocytic pathway. Membrane protein transport is orchestrated by abundant molecular components necessary to select cargo, form vesicles, and move vesicles towards the next compartment where they are tethered and fused with appropriate acceptor membranes. Each of these steps is The filters were first probed with phospho-specific antibodies (top panels) followed by activationindependent antibodies to check protein loading (bottom panels). Identical results were obtained in at least two independent experiments.
EGF receptor signaling in early endosomes O Kostenko et al intimately linked to signaling cascades elicited by receptor tyrosine kinases, which not only regulate specific transport events but are also influenced by cell compartmentalization (Sorkin and Von Zastrow, 2002) . One sorting station that has received wide attention is the multivesicular body (MVB), which buds from early endosomes and transports cargoes towards late endosomes ( Figure 10 ). Cargoes en route to lysosomes are sequestered in specialized subdomains on MVB limiting membranes that undergo inward invagination to form internal vesicles. The inward invagination step also removes activated receptors from the cytosol effectively quenching cell signaling for ErbB receptors undergoing downregulation. Data from this study indicate that EGFR-dependent cell signaling is also regulated before MVBs at the level of early endosomes. Wild-type receptors that are rapidly sequestered in EEA1 þ vesicles exhibit very modest Gab1 activation and transient MAPK signaling, compared to 679-AA receptors that are transported away from EEA1 þ vesicles towards Rab4 þ vesicles and which are associated with sustained signaling through these two signaling pathways. In contrast, Akt signaling is apparently unaffected by divergent 679-AA receptor trafficking, suggesting sequestration to specific early endosomal compartments controls a limited subset of EGFR-dependent cascades.
The Rab monomeric small GTPases are among the best-studied molecules that regulate flow through the endocytic pathway (Zerial and McBride, 2001) . Numerous studies have shown that Rab proteins are distributed to distinct endocytic compartments and regulate transport between organelles. GTP-bound activated Rab proteins bind a variety of effector proteins that transduce signals to endocytic transport mechanisms. Although their role in tethering vesicles to acceptor membranes has been known for several years, Rab proteins are now implicated in cargo selection, as well as vesicle budding and motility. Rab5 and Rab4 are two of the key small GTPase regulators in early endosomes (Bucci et al., 1992; van der Sluijs et al., 1992) . Rab5 regulates clathrin-coated vesicle-mediated transport from the plasma membrane to early endosomes as well as homotypic early endosome fusion (Simonsen et al., 1998) , and Rab4 is involved in sorting and recycling in early endosomes (Daro et al., 1996) . Although these two small GTPases often colocalize, they are not randomly distributed but are segregated to discrete membrane subdomains in the same endosome (Sonnichsen et al., 2000) . This applies to specific effector molecules, which also have nonrandom distribution in endosomes. For example, the Rab5 effector EEA1 that has been implicated in the docking of incoming endocytic vesicles before fusion with early endosomes, is absent from Rab5 þ clathrin-coated vesicles but exhibits a polarized distribution in early endosomes (Wilson et al., 2000) . There is also increasing evidence that Rab activity is coordinated by divalent effector molecules such as Rabaptin-5 that can bind to both Rab5 and Rab4 (Vitale et al., 1998; de Renzis et al., 2002) . þ but devoid of the Rab5 effector EEA1 (highlighted in gray). Rab5 and Rab4 are spatially segregated in early endosomes, and EEA1 exhibits a polar distribution consistent with Rab5-defined endosomal membrane domains. Wild-type receptors are transported from early to late endosomes via MVB transport intermediates (solid arrows). 679-AA receptors are rapidly sequestered away from EEA1 þ subdomains to Rab4 þ subdomains involved in recycling to the plasma membrane (dashed arrow). Our data suggest that Gab1/MAPK signaling persist when receptors are transported towards recycling vesicles, either because recycling endosomes provide the necessary environment for maintaining these signals, or because these pathways are quenched by transport to EEA1 þ early endosomes. The switch to sustained signaling does not require PI3K but is wortmannin sensitive. CCV, clathrin-coated vesicle; LE, late endosome; Ly, lysosome; MVB, multivesicular body.
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Phosphoinositol lipids generated by PI3K also regulate endocytic sorting at many different levels (Simonsen et al., 2001) . For example, EEA1 endosome recruitment is regulated by its ability to bind phosphoinositides through its FYVE domain (Simonsen et al., 1998) . Several studies utilize PI3K inhibitors, chiefly wortmannin, to dissect specific molecular requirements in the endocytic pathway. However, wortmannin has many other effects besides inhibiting PI3K, and sometimes gives discordant results compared to another widely used PI3K inhibitor LY294002. How might these alternative effects explain our observation that enhanced Gab1 and MAPK signaling is substantially reduced in cells expressing 679-AA receptors that are pretreated with wortmannin but not LY294002? One potential explanation involves the observation that wortmannin increases the affinity of the divalent effector Rabaptin5 for Rab5 (Chen and Wang, 2001 ), which could affect Rab5/Rab4 coordination. The second possibility relates to wortmannin's ability to inhibit myosin light chain kinase (Nakanishi et al., 1992) , which regulates nonmuscle myosin II that has recently been implicated in exocytosis and secretion (Krendel and Mooseker, 2005) . Either potential mode of action is consistent with the idea that Gab1 and/or MAPK signaling is regulated by early endosome sorting dynamics and/or motility. The simplest explanation for our data is that these signaling pathways are amplified by sequestration to Rab4 þ /EEA1 À subdomains in early endosomes. However, it is also possible that Gab1/MAPK signaling is actively turned off by rapid sequestration to Rab5 þ / EEA1 þ early endosomal membranes typical of wildtype receptors.
Gab1 was originally discovered in a yeast two-hybrid screen for Grb2 binding partners (Holgado-Madruga et al., 1996) . Two additional isoforms (Gab2 and Gab3) associated with overlapping as well as unique functions were subsequently identified (Zhao et al., 1999; Wolf et al., 2002; Gu and Neel, 2003) . Gab1 has multiple tyrosine phosphorylation sites involved in recruiting several signaling molecules including Shp2 (Cunnick et al., 2000; Cai et al., 2002) , PI-3 kinase (HolgadoMadruga et al., 1997) , and PLC-g (Gual et al., 2000) . Gab1 also has an amino-terminal PH domain facilitating membrane translocation. The Gab1 PH domain preferentially binds to phosphatidylinositol 3,4,5-triphosphate, a PI3K product enriched at plasma membrane (Isakoff et al., 1998; Maroun et al., 1999; Gillooly et al., 2000; Rodrigues et al., 2000) . Gab1 also has a novel Met binding domain (MBD) sequence enabling it to bind directly to some receptor tyrosine kinases (Lock et al., 2000) . Thus, Gab1 may be linked to activated receptor tyrosine kinases by direct or indirect protein-protein interactions, or by protein-lipid interactions (Gu and Neel, 2003) . Whereas some of these mechanisms are known to control Gab1 signaling synergistically (Rodrigues et al., 2000) , alternative activation schemes may also enable fine-tuning of Gab1 responses (Gu and Neel, 2003) . Although we cannot exclude a role for Grb2 as a binding intermediary, our data implicate direct binding to ligand-activated receptors as the primary means for sustained Gab1 signaling observed in 679-AA receptor expressing cells. Although our data indicate that interactions sufficient to activate Gab1 occur initially at the plasma membrane, they also indicate that Gab1 may be continuously associated with 679-AA receptors during transport through early endosomes. Wild-type receptors may similarly associate with Gab1 in early endosomes, but this interaction appears to be minimal and/or under strict temporal control because activated receptors are rapidly sorted away from these compartments to late endosomes.
Several studies have linked Gab1 overexpression to upregulated p44/42 MAPK activity in response to stimulation with cytokines and growth factors including EGF (Weidner et al., 1996; Takahashi-Tezuka et al., 1998; Rodrigues et al., 2000) . Moreover, fibroblasts from Gab1-deficient mice showed reduced MAPK activation compared to wild-type littermates (Itoh et al., 2000) . However, other studies have linked exogenous Gab1 expression to enhanced mitogenic activity upon EGF stimulation based on 3 H-thymidine incorporation, independent of increased MAPK signaling. Thus, additional factors such as the JNK pathway may be involved in Gab1-dependent pathways leading to cell proliferation, although we could not detect any obvious differences in JNK signaling in 679-AA receptor-expressing cells relative to cells with wild-type (unpublished data). It has also been reported that loss of its amino-terminal PH domain activates Gab1 transforming potential as measured by growth of carcinogentransformed carcinogen-treated Syrian hamster embryo cells in soft agar upon stimulation by growth factors, including EGF (Kameda et al., 2001) . Our data raise the possibility that sequestration to EEA1 À /Rab4 þ early endosomes uncouples EGF-dependent Gab1 activation from its requirement for PI3-dependent regulation leading to enhanced mitogenesis. Studies to evaluate whether 679-AA receptor-dependent signaling affects cell transformation which have been carried out in the nude mouse model are so far inconclusive because this receptor mutation also appears to impair ligandindependent crosstalk with integrin pathways necessary for cell survival (Balanis and Carlin, unpublished observation). Thus, this mutation's effect on EGFR physiology is much more complex than we initially hypothesized.
As mentioned, Gab1 is involved in many signaling pathways associated with cell proliferation and survival, and has a direct link to MAPK signaling through its interactions with the tyrosine phosphatase Shp2 (Cai et al., 2002) . Interestingly, missense mutations in the gene encoding Shp2 have recently been linked to Noonan syndrome (Fragale et al., 2004) , a developmental disorder characterized by dysmorphic facies, short stature, cardiac defects, and skeletal anomalies (Chakraborty, 2002) . Similar to results reported here for 679-AA receptors, Shp2 proteins encoded by DNAs with Noonan syndrome-causing mutations exhibited prolonged Gab1-dependent MAPK activity associated with increased cell proliferation after EGF stimulation (Fragale et al., 2004) . Given the link between EGFR sorting abnormalities and enhanced Gab1 activity seen in our studies, it will now be of interest to determine whether these Shp2 mutations also have an impact on EGFR trafficking.
Altogether our data suggest that the 679-LL signal controls accessibility to a subset of EGFR substrates involved in MAPK and Gab1 signaling, and implicate early Rab4 þ endosomes as a site for persistent Gab1 signaling. We also show for the first time that Gab1 is prominently activated in early endosomes in a breast cancer cell line characterized by extensive EGFR-ErbB2 heterodimerization. As EGFR endocytosis is a tightly regulated, stepwise process that requires the coordinated action of many elements in the sorting machinery, factors disrupting EGFR trafficking at other specific sorting steps may have distinct effects on signaling outcome. Thus, precise knowledge of how individual sorting steps are regulated is needed in order to understand uncontrolled cell proliferation associated with abnormal expression of ErbB2 receptors seen in many human diseases.
Materials and methods
Cell culture NR6 is an NIH 3T3-derived mouse cell line lacking endogenous EGFRs (Pruss and Herschman, 1977) . Stable NR6 cell lines expressing human wild-type EGFRs or receptors with 679-LL converted to 679-AA are described elsewhere (Kil et al., 1999; Kil and Carlin, 2000; Tsacoumangos et al., 2005) . Individual clones with matched levels of expression were selected by sterile cell sorting by flow cytometry after cells were stained with a human-specific EGFR antibody. Receptor phenotypes were originally confirmed in multiple independently derived stable cell lines to ensure that observed differences were due to the receptor construct expressed and not an artifact of single-cell cloning (Kil et al., 1999; Kil and Carlin, 2000) . Human breast carcinoma SK-BR-3 cells were obtained from the American Type Culture Collection (Manassas, VA, USA). NR6-derived cells and SKBR3 cells were maintained in Dulbecco's modified Eagle 0 s medium (DMEM) and McCoy's 5a medium, respectively, supplemented with 10% fetal bovine serum and 2 mM glutamine.
Antibodies and other reagents
Human-specific EGFR1 monoclonal antibody was produced in mice using the ascites method (Harlow and Lane, 1988) . Akt, phospho-Akt (Ser473), phospho-Gab1 (Tyr627), and phospho-p44/42 MAPK (Thr202/Tyr204) rabbit antibodies were purchased from Cell Signaling Technology (Beverly, MA, USA). EEA1, pan-Erk, Grb2, phosphotyrosine, Rab4, and Shc mouse monoclonal antibodies were purchased from BD Biosciences (San Jose, CA, USA). Rabbit antibodies to EGFR and Gab1 were from Research Diagnostics (Concord, MA, USA) and Upstate Biotechnology (Lake Placid, NY, USA), respectively, and ErbB2 and Gab1 goat antibodies were from Santa Cruz Biotechnology (San Diego, CA, USA). Fluorochrome-and HRP-conjugated secondary antibodies were from Jackson ImmunoResearch (West Grove, PA, USA), and Amersham (Piscataway, NJ, USA), respectively. Receptorgrade mouse EGF was purchased from Sigma, and Alexa Fluor 488-labeled EGF from Molecular Probes. Wortmannin and LY294002 were purchased from Calbiochem (La Jolla, CA, USA).
Cell harvesting
Denatured cellular protein was prepared by lysing cells with 1% sodium dodecyl sulfate (SDS) in 10 mM Tris, pH 7.4, preheated to 1001C. Two different buffers were used to harvest cells under native conditions. The first contained 1% NP-40 diluted in 20 mM Tris, pH 7.4, supplemented with 137 mM NaCl, 10% glycerol, 1 mM MgCl 2 , and 1 mM ethyleneglycoltetreacetate. The second contained 1% NP-40, 0.5% sodium deoxycholate, and 0.1% SDS diluted in 10 mM Na 2 HPO 4 , pH 7.35, 150 mM NaCl, and 0.2% sodium azide. Native lysis buffers were also supplemented with a cocktail of tyrosine phosphatase (1 mM orthovanadate, 0.1 mM ammonium molybdate, 20 mM b-glycerol phosphate, and 20 mM sodium fluoride) and protease (0.2 mM phenylmethylsulfonyl fluoride and 1 mM leupeptin) inhibitors.
Immunoprecipitations and immunoblotting
Immunoprecipitations were carried out using two different methods. First, samples were incubated with antibodies to specific proteins for 1 h followed by protein A-Sepharose CL-4B beads (Sigma; St Louis, MO, USA) for an additional 1 h at 41C. Second, samples were incubated with a biotin-conjugated phosphotyrosine antibody for 2 h followed by streptavidin beads (Pierce; Rockford, IL, USA) overnight at 41C. Immune complexes were washed three times with lysis buffer and then solubilized with Laemmli sample buffer. Protein samples were resolved by SDS-polyacrylamide gel electrophoresis (PAGE), and transferred to nitrocellulose filters using established protocols (Laemmli, 1970; Towbin et al., 1979) . Nitrocellulose filters were blocked with 1% fatty acid-free BSA dissolved in 10 mM Tris, pH 7.4, 100 mM NaCl, and 1% Tween-20 for phosphotyrosine blotting. All other filters were blocked with 5% dry milk dissolved in TBS-T (10 mM Tris, pH 7.6, 150 mM NaCl, and 0.1% Tween-20). Filters were incubated with primary antibodies overnight at 41C, followed by the appropriate HRP-conjugated secondary antibody for 1 h at room temperature, for detection by ECL (Amersham).
Metabolic labeling
Cells rinsed twice with amino-acid-deficient MEM (GIBCO; Carlsbad, CA, USA) were pulse-labeled with Express Protein Labeling Mix (1175 Ci/mmol; New England Nuclear (NEN), Wilmington, DE, USA) diluted in amino-acid-deficient MEM supplemented with 10% dialysed FBS and 0.2% BSA for 30-min. The radio-labeled cells were switched to medium containing a 10-fold excess of nonradioactive amino acids for 3 h to allow delivery of newly synthesized receptors to the plasma membrane (Kil et al., 1999) . Immunoprecipitates were resolved by SDS-PAGE, and gels were treated with En 3 Hance (NEN) for fluorographic detection.
3 H-thymidine incorporation assays Cells were seeded in six-well dishes at a density of 10 5 cells/ well. The freshly seeded cells were arrested in G1 under low serum conditions (0.5% FBS) for 18 h. G1-arrested cells were stimulated with EGF for 19 h followed by a 4 h incubation with 3 H-thymidine (2.5 mCi/ml from 70 to 85 Ci/mmol stock; NEN). The radioactive medium was removed, and the cells were rinsed twice with ice-cold PBS followed by a 30-min incubation with an ice-cold solution of 10% TCA. The TCA precipitate was solubilized with 0.2 N NaOH at room temperature overnight and then mixed with 5 ml ScintiVerse s scintillation fluid (Fisher Scientific, Pittsburgh, PA, USA).
EGF receptor signaling in early endosomes O Kostenko et al Radioactivity was determined by scintillation counting (Beckman LS 3801 Liquid Scintillation System). Cells incubated under parallel conditions were collected by trypsinization for cell counting. All experiments were performed in triplicate and the data are presented as the mean 3 H-thymidine incorporation adjusted to cell number7s.e.m.
Percoll gradient cell fractionation Cells were scraped in ice-cold TES buffer (10 mM triethanolamine, pH 7.2, 1 mM ethylenediamine-N, N, N 0 , N 0 -tetraacetic acid, and 0.25 M sucrose) supplemented with a protease inhibitor cocktail. Cells collected by low-speed centrifugation were resuspended in the same buffer and homogenized with 30 strokes of a Dounce homogenizer. The homogenate was diluted with an equal volume of fresh TES buffer, and centrifuged at 400 g for 10 min at 41C to precipitate unbroken cells and nuclei. Low speed postnuclear supernatants were adjusted to a final concentration of 17% Percoll (Pharmacia; Rockville, MD, USA) in 0.25 M sucrose. This solution was layered over a 2.5 M sucrose cushion and centrifuged for 50 min at 25 000 g in an SS-34 fixed-angle rotor without braking. A total of nine subcellular fractions were collected from the top of the gradient. Dense fractions 7-9 which were all positive for lysosomal markers were usually discarded since signaling molecules in these fractions are degraded and therefore undetectable without adding protease inhibitors to live cells . Percoll was removed by centrifuging each of the fractions twice for 30 min at 65 000 g. Subcellular membranes were incubated in TES buffer supplemented with 1% NP-40, 0.5% sodium deoxycholate, and 0.1% SDS for 30 min on ice. Samples were centrifuged at 60 000 g for 1 h to precipitate insoluble material, and soluble membrane fractions were saved for further analysis.
Confocal microscopy
Cells were permeabilized and fixed with 0.5% b-escin and 3% paraformaldehyde-PBS, respectively, as described previously (Crooks et al., 2000) . The cells were stained with primary and secondary antibodies diluted in PBS supplemented with 0.5% b-escin and 0.2% RIA-grade BSA for 1 h each at 371C. Cells were incubated with a solution containing 5% normal serum from the host animal used to generate secondary antibodies before the secondary antibodies were added to block nonspecific staining. Cells were examined with a Zeiss LSM 410 scanning laser confocal microscope using the 488/568-nm wavelength lines of the argon-krypton laser. Image resolution obtained with a Zeiss Â 100 Plan-Neofluor oil objective and Zeiss LSM software was 512 Â 512 pixels. 
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